drugset / Trial / NCT02531919

Extended Use of Sodium Bicarbonate in Patients With Cancer

NCT02531919

Phase 1 Completed 15 enrolled University of Arizona
NaSingle-groupOpen-labelTreatment

Summary

This pilot phase I trial studies the safety of long-term use of sodium bicarbonate in patients with cancer. Sodium bicarbonate may neutralize tumor acidity and as a result may inhibit the spread of the tumor to other parts of the body (metastases) and improve survival.

Timeline

Start
2013-08
Primary completion
2014-11
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium bicarbonate Diagnostic / imaging agent 0.5 g/kg Oral

Indications